Projekt
ONCODIR – Evidence-based Participatory Decision Making for Cancer Prevention through implementation research
Colorectal cancer (CRC) is one of the most common cancer types and its increased occurrence may be attributable to adverse health behaviors, especially in lower socioeconomic status populations. Stemming from the specific risk factors identified with CRC, ONCODIR integrates multidisciplinary research methods from heal…
Colorectal cancer (CRC) is one of the most common cancer types and its increased occurrence may be attributable to adverse health behaviors, especially in lower socioeconomic status populations. Stemming from the specific risk factors identified with CRC, ONCODIR integrates multidisciplinary research methods from health policy analytics; social and behavioural science; AI-powered multi-omics and retrospective data analytics as well as decision support theories to deliver evidence-based cancer prevention programmes and innovative AI-powered personalised prevention approaches. ONCODIR recognises that the evaluation of the ONCODIR prevention programmes needs to address cost effectiveness, affordability and cost benefit parameters. Thus it will also investigate cost balancing and demand generating financial schemes that will lead to enhanced CRC prevention programmes. The coherent technological ecosystem that ONCODIR is developing is based on robust AI trustworthiness and privacy preserving principles to deploy recommendation services that will be specified by citizens, health policy actors and SSH experts, during three design thinking workshops. SSH research will address aspects such as the life-status, nutritional and social habits in tandem with Economics, Sociology and Local/Regional Cultural identity and Ethics. ONCODIR’s results will be validated in three Laboratory Integration Tests (LITs) and three Large-scale Intervention Pilots (LIPs) in five EU member states, with the active involvement of medical scientists, health care providers, foundations and consortium experts. The ONCODIR consortium is composed of complementary partners, coming from multidisciplinary research, technological and SSH domains, with a proven track record of high-quality research capacity. The carefully structured workplan, embodies a holistic approach toward meeting the ONCODIR objectives and delivering feasible policy-supporting outcomes of significant exploitation potential. This action is part of the Cancer Mission cluster of projects on ‘Prevention and early detection.
Themengebiete
- Gesundheit Gesundheit – Überblick über Forschungsprojekte, Patente und Akteure im TechnologieAtlas.
Hochschulen
- INSTITUT CATALA D'ONCOLOGIA INSTITUT CATALA D'ONCOLOGIA – Hochschule bzw. Forschungseinrichtung mit Aktivitäten in Forschung und Innovati…
- UNIVERSIDAD DE LA RIOJA UNIVERSIDAD DE LA RIOJA – Hochschule bzw. Forschungseinrichtung mit Aktivitäten in Forschung und Innovation.
- LIETUVOS SVEIKATOS MOKSLU UNIVERSITETAS LIETUVOS SVEIKATOS MOKSLU UNIVERSITETAS – Hochschule bzw. Forschungseinrichtung mit Aktivitäten in Forschung…
- INSTITUTUL ONCOLOGIC PROF. DR. ALEXANDRU TRESTIOREANU BUCURESTI INSTITUTUL ONCOLOGIC PROF. DR. ALEXANDRU TRESTIOREANU BUCURESTI – Hochschule bzw. Forschungseinrichtung mit A…
Unternehmen
- CATALINK LIMITED CATALINK LIMITED – Unternehmen mit Aktivitäten in Forschung und Innovation.
- SYNYO GmbH SYNYO GmbH – Unternehmen mit Aktivitäten in Forschung und Innovation.
- BEIA CONSULT INTERNATIONAL SRL BEIA CONSULT INTERNATIONAL SRL – Unternehmen mit Aktivitäten in Forschung und Innovation.
- EY ADVISORY SPA EY ADVISORY SPA – Unternehmen mit Aktivitäten in Forschung und Innovation.
- MEDICAL EDUCATION RESEARCH AND INNOVATION CENTER S.R.L. MEDICAL EDUCATION RESEARCH AND INNOVATION CENTER S.R.L. – Unternehmen mit Aktivitäten in Forschung und Innova…